Table 1.
Difference of clinical characteristics between C1 and C2 subgroups.
| C1 | C2 | p. overall | |
|---|---|---|---|
| N=324 | N=197 | ||
| Age | 60.2 (12.2) | 61.2 (12.1) | 0.325 |
| Gender: | 0.032* | ||
| Female | 125 (38.6%) | 57 (28.9%) | |
| Male | 199 (61.4%) | 140 (71.1%) | |
| Grade: | <0.001* | ||
| G1 | 14 (4.32%) | 0 (0.00%) | |
| G2 | 164 (50.6%) | 60 (30.5%) | |
| G3 | 120 (37.0%) | 86 (43.7%) | |
| G4 | 22 (6.79%) | 50 (25.4%) | |
| GX | 4 (1.23%) | 1 (0.51%) | |
| AJCC: | <0.001* | ||
| Stage I | 193 (59.6%) | 69 (35.0%) | |
| Stage II | 35 (10.8%) | 21 (10.7%) | |
| Stage III | 61 (18.8%) | 62 (31.5%) | |
| Stage IV | 35 (10.8%) | 45 (22.8%) | |
| N: | 0.011* | ||
| N0 | 145 (44.8%) | 92 (46.7%) | |
| N1 | 4 (1.23%) | 11 (5.58%) | |
| NX | 175 (54.0%) | 94 (47.7%) | |
| M: | <0.001* | ||
| M0 | 269 (83.0%) | 148 (75.1%) | |
| M1 | 32 (9.88%) | 43 (21.8%) | |
| MX | 23 (7.10%) | 6 (3.05%) | |
| OS | 0.24 (0.43) | 0.47 (0.50) | <0.001* |
| PFI | 0.24 (0.43) | 0.40 (0.49) | <0.001* |
*P value <0.05 is considered statistically significant.
Summary descriptive table by groups of “Cluster”.